Evidence of dysregulation of dendritic cells in primary HIV infection.
about
Interferon-alpha, immune activation and immune dysfunction in treated HIV infectionCD169-dependent cell-associated HIV-1 transmission: a driver of virus disseminationThe plasmacytoid dendritic cell as the Swiss army knife of the immune system: molecular regulation of its multifaceted functionsKinetics of myeloid dendritic cell trafficking and activation: impact on progressive, nonprogressive and controlled SIV infectionsFriend or Foe: Innate Sensing of HIV in the Female Reproductive Tract.The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?Loss of NK stimulatory capacity by plasmacytoid and monocyte-derived DC but not myeloid DC in HIV-1 infected patients.Dendritic cell status modulates the outcome of HIV-related B cell disease progression.Systemic immune activation in HIV infection is associated with decreased MDC responsiveness to TLR ligand and inability to activate naive CD4 T-cells.Aging of the human innate immune system in HIV infection.Longitudinal changes of peripheral blood DC subsets and regulatory T cells in Chinese chronic HIV-1-infected patients during antiretroviral therapy.High CCR5 density on central memory CD4+ T cells in acute HIV-1 infection is mostly associated with rapid disease progression.Binding of HIV-1 gp120 to DC-SIGN promotes ASK-1-dependent activation-induced apoptosis of human dendritic cells.Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-α-producing and partially matured phenotypeDendritic cells in progression and pathology of HIV infection.Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapyAttenuated Listeria monocytogenes vectors overcome suppressive plasma factors during HIV infection to stimulate myeloid dendritic cells to promote adaptive immunity and reactivation of latent virus.Modulation of type I interferon-associated viral sensing during acute simian immunodeficiency virus infection in African green monkeys.Efficient infection, activation, and impairment of pDCs in the BM and peripheral lymphoid organs during early HIV-1 infection in humanized rag2⁻/⁻γ C⁻/⁻ mice in vivo.Plasmacytoid dendritic cell dynamics tune interferon-alfa production in SIV-infected cynomolgus macaques.Dendritic cell dysfunction during primary HIV-1 infection.Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis.Longitudinal changes in plasma Caspase-1 and Caspase-3 during the first 2 years of HIV-1 infection in CD4Low and CD4High patient groups.Blocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activationGeneralized immune activation and innate immune responses in simian immunodeficiency virus infectionInnate immunity in acute HIV-1 infectionLow CD1c + myeloid dendritic cell counts correlated with a high risk of rapid disease progression during early HIV-1 infection.DCs and NK cells: critical effectors in the immune response to HIV-1.Influence of dendritic cells on B-cell responses during HIV infection.Functional Impairment of Myeloid Dendritic Cells during Advanced Stage of HIV-1 Infection: Role of Factors Regulating Cytokine SignalingPreservation HIV-1-specific IFNγ+ CD4+ T-cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trialGut-Associated Plasmacytoid Dendritic Cells Display an Immature Phenotype and Upregulated Granzyme B in Subjects with HIV/AIDS.Characterization of peripheral and mucosal immune responses in rhesus macaques on long-term tenofovir and emtricitabine combination antiretroviral therapy.Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway.HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44A dendrite in every pie: myeloid dendritic cells in HIV and SIV infection.Virus-encoded TLR ligands reveal divergent functional responses of mononuclear phagocytes in pathogenic simian immunodeficiency virus infection.HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs.Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells
P2860
Q26861003-7384DAF0-1AE3-4991-A450-3BD3F74CC135Q27008186-187D0625-B62E-46C5-A5A2-006F017A2A23Q27023380-41330F8C-4946-47EC-ABF8-E4D6CF7F9D36Q27333255-EBB5D05E-70E5-40F8-B8C4-9FEDE5F74939Q33613121-39BF8974-20C1-440A-90F3-0FC2636088F1Q33662836-275502E3-7051-402D-8F54-13F7A2F40878Q33847612-925F098C-83F7-4BEA-83C4-5B9DAC70640EQ34013594-DFA0F78C-1B00-414D-9FA1-E559094CD486Q34017771-6D037CBB-B2B9-4DAF-81DA-3351443E7106Q34094201-3B580B1C-95DA-46E4-AF0D-DFBF294E810FQ34305055-3D9A1DF7-5B03-4E8A-BFF8-EC34B88E4B61Q34490116-2A35BF0D-2E87-4CB3-A005-C712466D1DE2Q34574823-133AB22A-DAC8-432F-9A9A-13BB446D9A4EQ34612545-B4948728-DA28-4946-BDA0-28B87E04642FQ34627162-60D47335-0F1F-4B49-B2B7-A29F254437BEQ34657557-87FA3243-DE80-48BF-8007-724086237EEDQ34749218-3A3D7F71-A045-44B8-AE48-068F243D274BQ34871958-4E9269CB-6DA9-4A62-9E1A-2BF00FE3642DQ34992745-C3BD185E-AFD2-4101-9A28-5C29E1452002Q35067382-6BE0E3F0-CD5D-4FEC-AE92-E1CC059D2979Q35086879-756C4DD3-BFA3-4FBC-A12D-B9E1BB1B2384Q35331473-39761794-3D40-489E-AE96-4F0568265A4FQ35553567-C34DEB9A-2D7E-4B3E-8126-028E1E209742Q35585958-1B1A8DCC-AD5E-4891-9914-0BA46D921F63Q35606616-D0276404-7D5E-4A4D-BDDA-83C7723392B2Q35681801-3EE2C25C-CC89-4611-A214-18B44F97406AQ35696991-B20D90E7-B890-40F5-B36D-53609D39ABC5Q35749350-9EE0E8FB-557C-4719-9440-C720D2E1D6C8Q35752667-4B56ED78-8AB0-474D-BA31-0C6BE5E681B8Q35810658-7E9C5DDB-C258-460E-9525-4AEAF4AB0106Q35817342-0F0CF9AF-E9B3-4EB8-97DC-21B2874AB86CQ36053228-155FF486-A5E9-454D-B00E-8D71F7FE8860Q36098352-3F441680-03B1-40EA-A356-86F26B4DB77FQ36389032-C98F6F7D-CCE9-467C-97E9-5097B8AC4381Q36427991-E118C201-1545-44DF-A5BA-A4398475E659Q36498061-645D4B68-71F7-4D9D-9CC8-8BB7852E82DBQ36535798-E455C016-8506-44F3-99F4-D2CA0925A1A3Q36625289-4E7D5ADA-8914-4C4B-BB35-E4E7397F7FA0Q36770954-914E1EB2-F360-4F3F-AE84-C5A7707DE9AEQ36797689-3A8AC138-9EBE-4E8F-AE4E-2BEEFB2DEC2C
P2860
Evidence of dysregulation of dendritic cells in primary HIV infection.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Evidence of dysregulation of dendritic cells in primary HIV infection.
@ast
Evidence of dysregulation of dendritic cells in primary HIV infection.
@en
Evidence of dysregulation of dendritic cells in primary HIV infection.
@nl
type
label
Evidence of dysregulation of dendritic cells in primary HIV infection.
@ast
Evidence of dysregulation of dendritic cells in primary HIV infection.
@en
Evidence of dysregulation of dendritic cells in primary HIV infection.
@nl
prefLabel
Evidence of dysregulation of dendritic cells in primary HIV infection.
@ast
Evidence of dysregulation of dendritic cells in primary HIV infection.
@en
Evidence of dysregulation of dendritic cells in primary HIV infection.
@nl
P2093
P2860
P50
P1433
P1476
Evidence of dysregulation of dendritic cells in primary HIV infection.
@en
P2093
Abhignya Subedi
Andrea Stacey
Arthur Nadas
Donald Garmon
Elizabeth Taylor
Frederick Siegal
Jeffrey Lifson
Kevin V Shianna
Kokila Shah
P2860
P304
P356
10.1182/BLOOD-2010-03-273763
P407
P577
2010-08-06T00:00:00Z